Stephane Berthier

About

An executive with strong scientific and business qualifications with an impressive track record of twenty-five years of hands-on experience in global research & development, commercial, business development, and project management, including fifteen years in oncology / hematology. Proven track record of driving innovation and growth in oncology, hematology, and rare diseases, across the full product lifecycle from early-stage development to global launch and commercialization.

Experience

• Chief Executive Officer at SDK Therapeutics
  2024 - Present · 2 yrs 7 mos

• US President & Chief Executive Officer at SymBio Pharma USA, Inc.
  2023 - 2024 · 1 yr

• U.S. General Manager at Atara Biotherapeutics
  2021 - 2023 · 2 yrs

• Vice President, Head of US Commercial at MorphoSys
  2019 - 2021 · 2 yrs

• Global Commercial Head, Leukemia & Lymphoma Franchise at The Janssen Pharmaceutical Companies of Johnson & Johnson
  2016 - 2019 · 3 yrs